What's Happening

You are here

[Issue No. 157] PSS E-Bulletin September 2019

In the spotlight is an initiative by PSS that features hospital pharmacists who excel in their area of practice and are role models for fellow pharmacists.

HSA Drug Safety Information Updates: Retail level recall of eight brands of ranitidine products found to contain N-nitrosodimethylamine (NDMA).

HSA adverse drug reaction including updates on E-labelling and guide on iatrogenic Cushing’s Syndrome and steroid-related adverse events

Singapore National Asthma Program -2 (SNAP2) has put together some key changes to the GINA guidelines in asthma management. The changes include the role of SABA-only treatment and ICS in asthma. Find out more in this bulletin.